Geode Capital Management, LLC Xeris Biopharma Holdings, Inc. Transaction History

Geode Capital Management, LLC

$1.39 Trillion
Q2 2025

A detailed history of Geode Capital Management, LLC transactions in Xeris Biopharma Holdings, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 3,650,688 shares of XERS stock, worth $26.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,650,688

Previous 3,405,826 7.19%

Holding current value

$26.7 Million

Previous $18.7 Million 8.82%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 08, 2025	BUY	$3.95 - $5.16 $967,204 - $1.26 Million	244,862 Added 7.19%	3,650,688 $17 Million
Q1 2025 May 13, 2025	BUY	$3.2 - $5.95 $174,080 - $323,680	54,400 Added 1.62%	3,405,826 $18.7 Million
Q4 2024 Feb 12, 2025	BUY	$2.78 - $3.73 $49,917 - $66,975	17,956 Added 0.54%	3,351,426 $11.4 Million
Q3 2024 Nov 12, 2024	BUY	$2.06 - $2.96 $191,767 - $275,549	93,091 Added 2.87%	3,333,470 $9.5 Million
Q2 2024 Aug 09, 2024	BUY	$1.7 - $2.45 $331,525 - $477,786	195,015 Added 6.4%	3,240,379 $7.29 Million
Q1 2024 May 13, 2024	BUY	$2.04 - $3.22 $312,705 - $493,584	153,287 Added 5.3%	3,045,364 $6.73 Million
Q4 2023 Feb 13, 2024	BUY	$1.47 - $2.36 $174,612 - $280,330	118,784 Added 4.28%	2,892,077 $6.8 Million
Q3 2023 Nov 13, 2023	BUY	$1.8 - $2.69 $164,678 - $246,102	91,488 Added 3.41%	2,773,293 $5.16 Million
Q2 2023 Aug 11, 2023	BUY	$1.82 - $2.98 $275,002 - $450,278	151,100 Added 5.97%	2,681,805 $7.03 Million
Q1 2023 May 15, 2023	BUY	$1.03 - $1.63 $100,933 - $159,730	97,994 Added 4.03%	2,530,705 $4.13 Million
Q4 2022 Feb 13, 2023	BUY	$1.14 - $1.65 $90,845 - $131,486	79,689 Added 3.39%	2,432,711 $3.24 Million
Q3 2022 Nov 14, 2022	BUY	$1.37 - $1.93 $245,871 - $346,373	179,468 Added 8.26%	2,353,022 $3.67 Million
Q2 2022 Aug 12, 2022	BUY	$1.48 - $2.64 $1.5 Million - $2.67 Million	1,011,664 Added 87.07%	2,173,554 $3.35 Million
Q1 2022 May 13, 2022	BUY	$2.0 - $2.87 $313,780 - $450,274	156,890 Added 15.61%	1,161,890 $2.97 Million
Q4 2021 Feb 11, 2022	BUY	$1.8 - $2.93 $541,494 - $881,431	300,830 Added 42.72%	1,005,000 $2.94 Million
Q3 2021 Nov 12, 2021	BUY	$2.2 - $4.25 $1.55 Million - $2.99 Million	704,170 New	704,170 $1.73 Million

Others Institutions Holding XERS

# of Institutions

207

Shares Held

89.5M

Call Options Held

81.6K

Put Options Held

57.6K

View Full List

About Xeris Biopharma Holdings, Inc.

Ticker XERS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,956,992
Market Cap $992M
Description
Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...

More about XERS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Xeris Biopharma Holdings, Inc. Transaction History